The European Medicines Agency (EMA) wants to suspend around 300 marketed generic meds (and applications) coming out of Indian CRO Micro Therapeutic Research Labs due to concerns over “misrepresentation of
Tag "suspension"
The agency is recommending the suspension of a variety of medications because of unreliable bioequivalence studies conducted by Micro Therapeutic Research Labs The European Medicines Agency (EMA) announced on March